Medical technology company Glenveigh Medical in Chattanooga is getting nearly half a million dollars in federal grants to pay for research that officials expect will boost America’s role in biomedical research.
The federal “therapeutic discovery” grants and tax credits, awarded under national health care reform legislation and announced this month, provide more than $6.7 million to Tennessee recipients whose projects show “significant potential to produce new and cost-saving therapies, support good jobs and increase U.S. competitiveness,” according to the U.S. Department of Health and Human Services.
The only Chattanooga-based company awarded the grant this year was Glenveigh, which specializes in maternal-fetal medicine products. The company moved from Research Triangle Park in Raleigh-Durham, N.C., to Chattanooga in 2007.
About $81,000 in grants will help Glenveigh create a device for measuring cervical dilation during labor, and an additional $156,000 will help the company develop treatment for pre-eclampsia, a dangerous condition for pregnant women.
The company also received $244,479 for a device that can slow blood loss in women hemorrhaging after giving birth, said the company’s founders.